Clinical management of female patients with Fabry disease based on expert consensus
Abstract Fabry disease is an X-linked lysosomal storage disorder that causes accumulation of glycosphingolipids in body tissues and fluids, leading to progressive organ damage and life-threatening complications. It can affect both males and females and can be classified into classic or later-onset p...
Saved in:
| Main Authors: | Eva Brand, Aleš Linhart, Patrick Deegan, Ruxandra Jurcut, Antonio Pisani, Roser Torra, Ulla Feldt-Rasmussen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-024-03500-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiomyopathy and kidney function in agalsidase beta‐treated female Fabry patients: a pre‐treatment vs. post‐treatment analysis
by: Christoph Wanner, et al.
Published: (2020-06-01) -
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
by: Malte Lenders, et al.
Published: (2025-02-01) -
Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs
by: Antonino Tuttolomondo, et al.
Published: (2025-03-01) -
Fabry Disease: An Update Based on Evidence and Experience
by: J. Politei, et al.
Published: (2025-06-01) -
Fabry disease phenotyping in women from the complete Romanian cohort – time for early diagnostic awareness
by: Mursă Adriana, et al.
Published: (2024-12-01)